Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When. Hernández-Ruiz, V., Forestier, E., Gavazzi, G., Ferry, T., Grégoire, N., Breilh, D., Paccalin, M., Goutelle, S., & Roubaud-Baudron, C. Journal of the American Medical Directors Association, 22(1):50–55.e6, January, 2021.
Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When [link]Paper  doi  bibtex   
@article{hernandez-ruiz_subcutaneous_2021,
	title = {Subcutaneous {Antibiotic} {Therapy}: {The} {Why}, {How}, {Which} {Drugs} and {When}},
	volume = {22},
	issn = {15258610},
	shorttitle = {Subcutaneous {Antibiotic} {Therapy}},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S1525861020303637},
	doi = {10.1016/j.jamda.2020.04.035},
	language = {en},
	number = {1},
	urldate = {2022-02-24},
	journal = {Journal of the American Medical Directors Association},
	author = {Hernández-Ruiz, Virgilio and Forestier, Emmanuel and Gavazzi, Gaëtan and Ferry, Tristan and Grégoire, Nicolas and Breilh, Dominique and Paccalin, Marc and Goutelle, Sylvain and Roubaud-Baudron, Claire},
	month = jan,
	year = {2021},
	pages = {50--55.e6},
}

Downloads: 0